Genetic predisposition of responsiveness to therapy for chronic hepatitis C.
about
Gene expression and hepatitis C virus infectionEvolution of interferon-based therapy for chronic hepatitis C.Genetic polymorphisms associated with rubella virus-specific cellular immunity following MMR vaccinationPharmacogenomics of drug efficacy in the interferon treatment of chronic hepatitis C using classification algorithms.Molecular and contextual markers of hepatitis C virus and drug abuse.Atopy history and the genomics of wheezing after influenza vaccination in children 6-59 months of age.Pattern-recognition techniques with haplotype analysis in pharmacogenomics.Pharmacogenomics of chronic hepatitis C therapy with genome-wide association studies.Role of viral and host factors in interferon based therapy of hepatitis C virus infectionTGF-β receptor maintains CD4 T helper cell identity during chronic viral infectionsADARs: viruses and innate immunity.Hepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirin.Assessing gene-gene interactions in pharmacogenomics.Pharmacogenomics in Asia: a systematic review on current trends and novel discoveries.Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirin.A support vector machine approach to assess drug efficacy of interferon-alpha and ribavirin combination therapy.Gene-gene and gene-environment interactions in interferon therapy for chronic hepatitis C.Evolving Trends in the Hepatitis C Virus Molecular Epidemiology Studies: From the Viral Sequences to the Human Genome
P2860
Q27488345-72BF155D-EF5C-49D5-B9C0-A68950B78846Q34342092-666F7407-2A03-4410-993D-96E168532A9AQ34599856-5E43CDAE-EC88-4965-85F9-0F2E23760B1FQ35205520-64D31A64-704B-4ACF-AE87-423A064AC2BFQ35660841-A48DA35D-6CC0-4912-8422-C31CA9C6289DQ35906659-3519B720-D61F-48B1-90CA-C36E00798C7EQ36691786-3B0EF871-8294-4318-B5C8-48F2A6448547Q36890411-B6DF5E6E-DA11-45B1-B957-311ACF7754F8Q37362240-02D0F8A4-2E7C-4038-9954-E2A2939BD196Q37395668-9082A741-CE39-4EA3-BD1E-706E8E14884DQ37401773-6272F8CA-502F-4413-821D-F22908E3F465Q37772959-B5EC025E-84A9-4000-88C6-EE4A464028D4Q37986775-2CAF6649-B704-48C8-91CF-A4ECE042DA23Q39359391-2FCAFFBF-0869-47CC-A4E1-C4210C1D5608Q42382462-AB84B253-D283-44F4-AFFC-C91768CFEED2Q42980284-017939DF-F371-43CF-BC14-3440EF5BC798Q50569876-FF767616-9EBA-4D80-8B29-8B0929BB1077Q58701375-C2D80675-5B01-40CD-99F7-35860DEF3B02
P2860
Genetic predisposition of responsiveness to therapy for chronic hepatitis C.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Genetic predisposition of responsiveness to therapy for chronic hepatitis C.
@en
Genetic predisposition of responsiveness to therapy for chronic hepatitis C.
@nl
type
label
Genetic predisposition of responsiveness to therapy for chronic hepatitis C.
@en
Genetic predisposition of responsiveness to therapy for chronic hepatitis C.
@nl
prefLabel
Genetic predisposition of responsiveness to therapy for chronic hepatitis C.
@en
Genetic predisposition of responsiveness to therapy for chronic hepatitis C.
@nl
P2093
P2860
P356
P1433
P1476
Genetic predisposition of responsiveness to therapy for chronic hepatitis C.
@en
P2093
Chia-Yen Dai
Chuan-Mo Lee
Ding-Shinn Chen
Ellson Y Chen
Jing-Houng Wang
Ming-Lung Yu
Ming-Yang Lai
Monica Shian-Jy Bey
Pei-Jer Chen
Wan-Long Chuang
P2860
P304
P356
10.2217/14622416.7.5.697
P577
2006-07-01T00:00:00Z